CYP21A2 Gene Amplification for Chimera Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for sequencing the CYP21A2 gene are confounded by the sequence similarity and variations of the CYP21A1P pseudogene, leading to ineffective amplification of the gene and failure to detect chimeras between CYP21A2 and the pseudogene.
Innovation Solution
A method using PCR with a forward primer complementary to a duplicated sequence in the bimodular RCCX locus and a reverse primer complementary to a unique sequence downstream of the CYP21A2 gene, allowing for the amplification of the CYP21A2 gene and its chimeras, and subsequent next-generation sequencing for mutation analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional PCR primers are designed to amplify only the CYP21A2 gene, then amplification specificity is improved, but the ability to detect chimeras between CYP21A2 and the pseudogene is lost
Solution Approach 1:
The amplification process is divided into two stages: first, a long-range PCR amplifies the entire CYP21A2 gene and flanking regions including the pseudogene; second, the product is segmented into multiple smaller amplicons for sequencing. This segmentation allows the first stage to capture all variants including chimeras, while the second stage provides detailed analysis of specific regions.
Solution Approach 2:
The approach transitions from traditional single-stage PCR to a two-dimensional amplification strategy: first amplifying the entire locus including pseudogene regions, then sequencing specific segments. This dimensional expansion enables simultaneous detection of wild-type, mutant, and chimera variants that would be invisible to conventional single-stage methods.
2Adaptability or versatility
If the CYP21A1P pseudogene sequence is considered during amplification, then detection of all variants is improved, but amplification efficiency and accuracy of the CYP21A2 gene is reduced
Solution Approach 1:
The method extracts and sequences only the relevant portions of the amplified product that correspond to the CYP21A2 gene coding regions and critical flanking areas. By focusing sequencing efforts on specific segments rather than the entire pseudogene, the method maintains high accuracy for CYP21A2 analysis while still detecting chimeras that involve the pseudogene.
Solution Approach 2:
Different regions of the amplified product are treated with different analytical approaches: the CYP21A2 coding regions are sequenced with high stringency for mutation detection, while the pseudogene regions are analyzed specifically for chimera formation. This localized quality control allows simultaneous optimization for both gene accuracy and variant detection.
3Ease of manufacture
If conventional PCR methods are used for CYP21A2 amplification, then simplicity of the method is maintained, but the method fails to amplify chimeras and provides incomplete diagnostic information
Solution Approach 1:
The method performs preliminary long-range PCR amplification of the entire CYP21A2 locus and flanking regions before proceeding to targeted sequencing. This preliminary action ensures that all potential variants including chimeras are captured in the amplification product, providing complete diagnostic information while maintaining a relatively simple overall protocol.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively amplifies the CYP21A2 gene and its chimeras, enabling accurate identification of mutations and improving the analysis of the CYP21A2 gene, particularly in cases with rearrangements or chimeras, thereby enhancing diagnostic capabilities for congenital adrenal hyperplasia.
Implementation Method 1
amplifying a product from a sample comprising human genomic DNA by PCR using a forward primer that is complementary to a sequence that is duplicated in the bimodular human RCCX locus and a reverse primer that is complementary to a sequence that occurs only once in the bimodular human RCCX locus at a position that is downstream of the CYP21A2 gene
Data Source
AI summary
A method for amplifying a CYP21A2 gene and/or a CYP21A2 gene chimera from a sample is provided. In some embodiments, the method may comprise amplifying a product from a sample comprising human genomic DNA by PCR using a forward primer that is complementary to a sequence that is duplicated in a bimodular human RCCX locus and a reverse primer that is complementary to a sequence that occurs only once in the bimodular human RCCX locus at a position that is downstream of the CYP21A2 gene. Methods for analyzing the amplification product are also provided.